BO-112

BO-112 · Highlight Therapeutics

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BO-112, covering 2022-07-19 to 2026-03-10. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma [Phase 1]